Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1701
-
1702
-
1703
Data Sheet 2_Reducing ocular Demodex using petroleum jelly may alleviate dry eye syndrome, blepharitis, facial dermatoses, ocular and respiratory allergies, and decrease associated...
Published 2025“…Mean yearly issues of anti-allergy and antimicrobial medicines reduced from 15.6 (range 8–25) to 1.8 (range 0–4), representing an 88.5% decrease for Volunteer 1 and from 5.8 (range 3–9) and 14.2 issues (range 9–24) to zero for both Volunteer 2 and Volunteer 13 respectively, representing 100% reductions in prescribing. …”
-
1704
Data Sheet 1_Reducing ocular Demodex using petroleum jelly may alleviate dry eye syndrome, blepharitis, facial dermatoses, ocular and respiratory allergies, and decrease associated...
Published 2025“…Mean yearly issues of anti-allergy and antimicrobial medicines reduced from 15.6 (range 8–25) to 1.8 (range 0–4), representing an 88.5% decrease for Volunteer 1 and from 5.8 (range 3–9) and 14.2 issues (range 9–24) to zero for both Volunteer 2 and Volunteer 13 respectively, representing 100% reductions in prescribing. …”
-
1705
-
1706
-
1707
-
1708
-
1709
-
1710
-
1711
-
1712
Expression of VGLUT1 increases while VGLUT2 decreases at individual presynaptic puncta during postnatal synapse development.
Published 2013“…Only puncta that expressed VGLUT1 and VGLUT2 were included in this analysis. (<b>E–F</b>) The mean intensity of VGLUT1 increased (E) while VGLUT2 decreased (F) at presynaptic puncta during early postnatal development. …”
-
1713
-
1714
-
1715
-
1716
-
1717
-
1718
-
1719
The NK1-receptor antagonist ezlopitant significantly decreases voluntary intake of sucrose using the drinking in the dark model in mice.
Published 2013“…<p>The highest dose of ezlopitant (15 mg/kg) decreased consumption of 5% sucrose (<b>A</b>). However, ezlopitant treatment failed to induce a significant decrease in ethanol consumption compared to vehicle (<b>B</b>). …”
-
1720
PI(3)P and VPS34 lipid kinase activity is decreased in <i>Becn1</i> deficient MEFs.
Published 2014“…Quantification of normalized <sup>32</sup>P-labelled PI(3)P from 3 separate experiments. Bars represent mean +/− s.e.m. (n = 3) con vs. def p<0.0001 using a one sample t-test (two-tailed). …”